Alger Health Sciences Portfolio

2 / 5 Stars
1 1 5 3 2
Zacks Investment Research
2 (Buy)
Standard & Poor's
2 / 5 Stars
A- (Buy)

#27 in Health

U.S. News evaluated 34 Health Funds. Our list highlights the top-rated funds for long-term investors based on the ratings of leading fund industry researchers.

See all Alger funds

See full Health rankings

See more fund rankings


The fund has returned 38.77 percent over the past year, 19.56 percent over the past three years, 21.43 percent over the past five years, and 11.49 percent over the past decade.

Trailing Returns Updated 02.28.2014
Year to date 8.9%
1 Year 38.8%
3 Years (Annualized) 19.6%
5 Years (Annualized) 21.4%
10 Years (Annualized) 11.5%

See more AHSAX performance


The investment seeks long-term capital appreciation. The fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of companies of any market capitalization that are engaged in the health sciences sector. It can also invest in derivative instruments.


Fees are Low compared to funds in the same category.
Alger Health Sciences Portfolio has an expense ratio of 1.35 percent.

See more AHSAX fees


Risk is Below Average compared to funds in the same category according to Morningstar.

See more AHSAX risk